AI assistant
Pacira BioSciences, Inc. — Director's Dealing 2013
May 21, 2013
32125_dirs_2013-05-21_38510c3f-b019-42a8-a50b-bf3bbfcdeef5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2013-05-20
Reporting Person: EVNIN LUKE (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-20 | Common Stock | S | 13550 | $30.00 | Disposed | 1183712 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 22746 | Direct |
Footnotes
F1: This transaction was pursuant to a 10b5-1 Plan.
F2: The shares were sold as follows: 12,699 by MPM BioVentures IV-QP, L.P. ("BV IV QP"), 489 by MPM BioVentures IV GmbH & Co. Beteiligungs KG ("BV IV KG") and 362 by MPM Asset Management Investors BV4 LLC ("AM BV4"). MPM BioVentures IV GP LLC and MPM BioVentures IV LLC ("BV LLC") are the direct and indirect general partners of BV IV QP and BV IV KG and BV LLC is the manager of AM BV4. The Reporting Person is a member of BV LLC.
F3: The shares are held as follows: 1,109,452 by BV IV QP, 42,745 by BV IV KG and 31,515 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.